Date: May 20, 2022
Biosimilars: Safe, Effective, & May Reduce Patient Costs
Biosimilars are safe and effective for treating many illnesses, including chronic skin diseases, inflammatory bowel diseases, arthritis, kidney conditions, diabetes, and cancer. Get an U.S. Food and Drug Administration (FDA) Overview of Biosimilar Products. Bookmark FDA’s Biosimilars webpage and materials for health care providers and patients.
Additional FDA resources you may find helpful: